Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and ...

Poherdy is the first FDA-approved interchangeable biosimilar to Perjeta for HER2-positive breast cancer, potentially expanding access and reducing costs. Approved for use in combination with ...

A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most ...

Private certification, insurer evaluation and peer-reviewed research step up.

Study reveals a gap FDA approval AI radiology devices with only 29% undergoing clinical testing before clearance.

As deadly drug overdoses climbed across Canada, decision-makers faced political backlash for funding programs that gave drug ...